During a session at the this week’s World Stem Cell Summit in San Diego, an international research team described an “astonishing” experiment in which a mouse model of multiple sclerosis was able to virtually totally recover and move normally after being transplanted with human neural precursor cells (hNPC). The scientists were able to show almost full recovery in the mice up to six months later.
Recent Posts
- Stem cell model replicates human amniotic sac development past two weeks
- Infant becomes world’s first patient to undergo personalized gene-editing treatment
- Biotech Tango dances away from preclinical work to extend cash runway, while Avalo lays out spending options
- Embryonic macrophages found to control blood stem cell numbers in bone marrow
- Federal appeals court sends CRISPR-Cas9 patent case back to patent office for reconsideration
- The stem cell race for Parkinson’s disease: Recent studies show significant promise